Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Chemokines and their receptors in allograft rejection.

Hancock WW, Gao W, Faia KL, Csizmadia V.

Curr Opin Immunol. 2000 Oct;12(5):511-6. Review.

PMID:
11007352
3.

Early expression of interferon-gamma inducible protein 10 and monokine induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells.

Kapoor A, Morita K, Engeman TM, Koga S, Vapnek EM, Hobart MG, Fairchild RL.

Transplantation. 2000 Mar 27;69(6):1147-55.

PMID:
10762220
4.

Chemokines: a new classification system and their role in immunity.

Zlotnik A, Yoshie O.

Immunity. 2000 Feb;12(2):121-7. Review. No abstract available.

5.

International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Murphy PM, Baggiolini M, Charo IF, H├ębert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA.

Pharmacol Rev. 2000 Mar;52(1):145-76. Review.

6.

Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.

Gao W, Topham PS, King JA, Smiley ST, Csizmadia V, Lu B, Gerard CJ, Hancock WW.

J Clin Invest. 2000 Jan;105(1):35-44.

7.

Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.

Topham PS, Csizmadia V, Soler D, Hines D, Gerard CJ, Salant DJ, Hancock WW.

J Clin Invest. 1999 Dec;104(11):1549-57.

8.

Structure and function of the murine chemokine receptor CXCR3.

Lu B, Humbles A, Bota D, Gerard C, Moser B, Soler D, Luster AD, Gerard NP.

Eur J Immunol. 1999 Nov;29(11):3804-12.

9.
10.

The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3.

Soto H, Wang W, Strieter RM, Copeland NG, Gilbert DJ, Jenkins NA, Hedrick J, Zlotnik A.

Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8205-10.

11.

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.

Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K.

J Exp Med. 1998 Jun 15;187(12):2009-21.

12.

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.

Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B.

J Exp Med. 1996 Sep 1;184(3):963-9.

13.

Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.

Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13967-72.

14.

Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha.

Rani MR, Foster GR, Leung S, Leaman D, Stark GR, Ransohoff RM.

J Biol Chem. 1996 Sep 13;271(37):22878-84.

15.

HuMig: a new human member of the chemokine family of cytokines.

Farber JM.

Biochem Biophys Res Commun. 1993 Apr 15;192(1):223-30.

PMID:
8476424
16.

Human Mig chemokine: biochemical and functional characterization.

Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM.

J Exp Med. 1995 Nov 1;182(5):1301-14.

17.

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

Springer TA.

Cell. 1994 Jan 28;76(2):301-14. Review. No abstract available.

PMID:
7507411
19.

Cells mediating allograft rejection.

Hall BM, Dorsch SE.

Immunol Rev. 1984;77:31-59. Review. No abstract available.

PMID:
6232202
20.

Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).

Luster AD, Ravetch JV.

J Exp Med. 1987 Oct 1;166(4):1084-97.

Supplemental Content

Support Center